Morini, M.; Raggi, F.; Bartolucci, M.; Petretto, A.; Ardito, M.; Rossi, C.; Segalerba, D.; Garaventa, A.; Eva, A.; Cangelosi, D.;
et al. Plasma-Derived Exosome Proteins as Novel Diagnostic and Prognostic Biomarkers in Neuroblastoma Patients. Cells 2023, 12, 2516.
https://doi.org/10.3390/cells12212516
AMA Style
Morini M, Raggi F, Bartolucci M, Petretto A, Ardito M, Rossi C, Segalerba D, Garaventa A, Eva A, Cangelosi D,
et al. Plasma-Derived Exosome Proteins as Novel Diagnostic and Prognostic Biomarkers in Neuroblastoma Patients. Cells. 2023; 12(21):2516.
https://doi.org/10.3390/cells12212516
Chicago/Turabian Style
Morini, Martina, Federica Raggi, Martina Bartolucci, Andrea Petretto, Martina Ardito, Chiara Rossi, Daniela Segalerba, Alberto Garaventa, Alessandra Eva, Davide Cangelosi,
and et al. 2023. "Plasma-Derived Exosome Proteins as Novel Diagnostic and Prognostic Biomarkers in Neuroblastoma Patients" Cells 12, no. 21: 2516.
https://doi.org/10.3390/cells12212516
APA Style
Morini, M., Raggi, F., Bartolucci, M., Petretto, A., Ardito, M., Rossi, C., Segalerba, D., Garaventa, A., Eva, A., Cangelosi, D., & Bosco, M. C.
(2023). Plasma-Derived Exosome Proteins as Novel Diagnostic and Prognostic Biomarkers in Neuroblastoma Patients. Cells, 12(21), 2516.
https://doi.org/10.3390/cells12212516
